The new research programme SPARC has been awarded a prestigious NWO Perspectief grant. This national funding supports large collaborations between researchers and industry to create innovations with real impact on society.

As the year draws to a close, the Oncode community once again gathered at the iconic Royal Tropical Institute in Amsterdam for two days of science, inspiration, and connection.

During the Dutch Life Sciences Conference, Myriagon was announced as the winner of the Venture Challenge Fall 2025.

Researchers have discovered a potent group of T cells that physically cling to tumour cells. The study, led by Oncode Investigator Daniel Peeper and published in Nature, opens a new direction for improving immunotherapy.

Oncode Researchers develop a faster, more flexible way to find new medicines - no DNA tags required.

After 30 years of mystery, scientists reveal how BRCA2-deficient tumors evade chemotherapy, and how we might stop them.

From DNA to RNA to proteins, the event highlighted cutting-edge methods redefining how scientists map, measure, and model the central dogma.

Are you passionate about the latest digital marketing trends and looking to take your career to the next level? Join our dynamic team at Oncode Institute!

What happens when a gene guards its own power source? Researchers discovered that Sox2 keeps its enhancer in check, revealing new rules of genome organization.

Could tiny molecules from your gut decide whether cancer treatment works? New research suggests they just might.

How can scientists unlock gene regulation secrets in our DNA? At the Oncode Masterclass, researchers explored ATAC-seq to study chromatin accessibility.

Could timing chemo with the menstrual cycle improve breast cancer treatment? That’s the bold question Oncode Researcher Laura Bornes was addressing during her PhD. 

Scientists have uncovered a hidden “histone supply chain” weakness that could re-sensitize even drug-resistant cancers to treatment, opening a new path to outsmart tumor resistance.

Researchers have discovered that RNA helps untie dangerous DNA “knots,” revealing a surprising new safeguard that keeps our genome stable and cancer at bay.

A new study conducted by Oncode Investigator Jan Hoeijmakers (Princess Máxima Center and Erasmus MC) and Oncode Researcher Wilbert Vermeij (Princess Máxima Center) shows that a brief period of fasting prior to cancer treatment appears to be safe and feasible for children.

Oncode Institute is proud to congratulate Oncode Investigator Sjoerd van der Burg (Leiden University Medical Center & Oncode Institute) on receiving the 2025 Pedro J. Romero Service to JITC Award.